VG Life Sciences Competitors and Similar CompaniesClear all
Syndax Pharmaceuticals's competitors and similar companies include Oncolytics Biotech.
 Syndax Pharmaceuticals Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy. |  Oncolytics Biotech Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies. | |
Founding Date | Founding Date 2005 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ New York, US Waltham, US | Locations Calgary, CA HQ Calgary, CA San Diego, US |
Employees | Employees 358% decrease | Employees 28 |
Valuation ($) | Valuation ($) 1.6 b | Valuation ($) 93.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $172.4m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($285.4m) (FY, 2025) | Net income ($28.8m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oncolytics Biotech
HQ
Calgary, CA
Employees
28
Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies.
View company